Teva Pharmaceutical Valuation
| TEV Stock | 15.05 0.15 1.01% |
At this time, the company appears to be undervalued. Teva Pharmaceutical has a current Real Value of USD16.24 per share. The regular price of the company is USD15.05. Our model measures the value of Teva Pharmaceutical from inspecting the company fundamentals such as Cash Flow From Operations of 1.59 B, current valuation of 28.17 B, and Revenue of 14.93 B as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Teva Pharmaceutical's price fluctuation is not too volatile at this time. Calculation of the real value of Teva Pharmaceutical is based on 3 months time horizon. Increasing Teva Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Teva Pharmaceutical's intrinsic value may or may not be the same as its current market price of 15.05, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.05 | Real 16.24 | Hype 14.75 | Naive 14.01 |
The intrinsic value of Teva Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Teva Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Teva Pharmaceutical Industries helps investors to forecast how Teva stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Teva Pharmaceutical more accurately as focusing exclusively on Teva Pharmaceutical's fundamentals will not take into account other important factors: Teva Pharmaceutical Total Value Analysis
Teva Pharmaceutical Industries is at this time anticipated to have takeover price of 28.17 B with market capitalization of 7.82 B, debt of 19.1 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Teva Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
28.17 B | 7.82 B | 19.1 B |
Teva Pharmaceutical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Teva implies not a very effective usage of assets in March.Teva Pharmaceutical Profitability Analysis
The company reported the revenue of 14.93 B. Net Loss for the year was (2.35 B) with profit before overhead, payroll, taxes, and interest of 0.About Teva Pharmaceutical Valuation
The stock valuation mechanism determines Teva Pharmaceutical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Teva Pharmaceutical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Teva Pharmaceutical. We calculate exposure to Teva Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Teva Pharmaceutical's related companies.8 Steps to conduct Teva Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Teva Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Teva Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Teva Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Teva Pharmaceutical's revenue streams: Identify Teva Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Teva Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Teva Pharmaceutical's growth potential: Evaluate Teva Pharmaceutical's management, business model, and growth potential.
- Determine Teva Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Teva Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Teva Stock Analysis
When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.